Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'HALOPERIDOL' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 3111 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Raggi, MA; Pucci, V; Sabbioni, C; Furlanetto, S; Gerra, G
      Simultaneous determination of plasma catecholamine metabolites (homovanillic acid, 3,4-dihydroxy phenyl acetic acid, 3-methoxy-4-hydroxy-phenylglycol) using liquid chromatography with amperometric detection

      JOURNAL OF SEPARATION SCIENCE
    2. Berlind, A
      Effects of haloperidol and phentolamine on the crustacean cardiac ganglion

      COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY
    3. Smith, RC; Infante, M; Singh, A; Khandat, A
      The effects of olanzapine on neurocognitive functioning in medication-refractory schizophrenia

      INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
    4. Beumer, JH; Bosman, IJ; Maes, R
      Hair as a biological specimen for therapeutic drug monitoring

      INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    5. Peuskens, J; De Hert, M; Jones, M
      The clinical value of risperidone and olanzapine: A meta-analysis of efficacy and safety

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    6. Haut, F; Clos, S
      Acute akathisia and sodium valproate

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    7. Jarema, M; Konieczynska, Z
      Quality of life in schizophrenia: Impact of psychopathology, patients' gender and antipsychotic treatment

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    8. Khouzam, HR; Gazula, K
      Clinical experience with olanzapine in the course of post-operative delirium associated with psychosis in geriatric patients: A report of three cases

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    9. Devoto, P; Flore, G; Pani, L; Gessa, G
      Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex

      MOLECULAR PSYCHIATRY
    10. Melone, M; Vitellaro-Zuccarello, L; Vallejo-Illarramendi, A; Perez-Samartin, A; Matute, C; Cozzi, A; Pellegrini-Giampietro, DE; Rothstein, JD; Conti, F
      The expression of glutamate transporter GLT-1 in the rat cerebral cortex is down-regulated by the antipsychotic drug clozapine

      MOLECULAR PSYCHIATRY
    11. Mirnics, K; Middleton, FA; Stanwood, GD; Lewis, DA; Levitt, P
      Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia

      MOLECULAR PSYCHIATRY
    12. Kitabayashi, Y; Ueda, H; Narumoto, J; Iizumi, H; Tsuchida, H; Murata, N; Nakajima, S; Fukui, K
      Chronic high-dose nitrazepam dependence I-123-IMP SPECT and EEG studies

      ADDICTION BIOLOGY
    13. Del Compare, JA; Aguirre, JA; Ibarra, FR; Barontini, M; Armando, I
      Effects of thyroid hormone on the renal dopaminergic system

      ENDOCRINE
    14. Ananth, J; Burgoyne, KS; Gadasalli, R; Aquino, S
      How do the atypical antipsychotics work?

      JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    15. Marcotte, ER; Pearson, DM; Srivastava, LK
      Animal models of schizophrenia: a critical review

      JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    16. Tempier, R; Pawliuk, N
      Influence of novel and conventional antipsychotic medication on subjectivequality of life

      JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    17. Purdon, SE; Malla, A; Labelle, A; Lit, W
      Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol

      JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    18. Khullar, A; Chue, P; Tibbo, P
      Quetiapine and obsessive-compulsive symptoms (OCS): case report and reviewof atypical antipsychotic-induced OCS

      JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    19. Tauscher, J; Kapur, S
      Choosing the right dose of antipsychotics in schizophrenia - Lessons from neuroimaging studies

      CNS DRUGS
    20. Desai, HD; Seabolt, J; Jann, MW
      Smoking in patients receiving psychotropic medications - A pharmacokineticperspective

      CNS DRUGS
    21. Noordsy, DL; O'Keefe, C; Mueser, KT; Xie, HY
      Six-month outcomes for patients who switched to olanzapine treatment

      PSYCHIATRIC SERVICES
    22. Sessler, CN; Grap, MJ; Brophy, GM
      Multidisciplinary management of sedation and analgesia in critical care

      SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
    23. Osser, DN; Sigadel, R
      Short-term inpatient pharmacotherapy of schizophrenia

      HARVARD REVIEW OF PSYCHIATRY
    24. Salzman, C; Tune, L
      Neuroleptic treatment of late-life schizophrenia

      HARVARD REVIEW OF PSYCHIATRY
    25. Patel, JK; Caplan, B; Green, A; Tamminga, C
      First-episode psychosis: Critical management issues during the first two years

      HARVARD REVIEW OF PSYCHIATRY
    26. Schneider, LS; Tariot, PN; Lyketsos, CG; Dagerman, KS; Davis, KL; Davis, S; Hsiao, JK; Jeste, DV; Katz, IR; Olin, JT; Pollock, BG; Rabins, PV; Rosenheck, RA; Small, GW; Lebowitz, B; Lieberman, JA
      National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) - Alzheimer disease trial methodology

      AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
    27. Reeves, RR; Mack, JE; Torres, RA
      Neuroleptic malignant syndrome during a change from haloperidol to risperidone

      ANNALS OF PHARMACOTHERAPY
    28. Schmajuk, NA
      Hippocampal dysfunction in schizophrenia

      HIPPOCAMPUS
    29. Posey, DJ; Guenin, KD; Kohn, AE; Swiezy, NB; McDougle, CJ
      A naturalistic open-label study of mirtazapine in autistic and other pervasive developmental disorders

      JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
    30. Van Bellinghen, M; De Troch, C
      Risperidone in the treatment of behavioral disturbances in children and adolescents with borderline intellectual functioning: A double-blind, placebo-controlled pilot trial

      JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
    31. Mehler, C; Wewetzer, C; Schulze, U; Warnke, A; Theisen, F; Dittmann, RW
      Olanzapine in children and adolescents with chronic anorexia nervosa. A study of five cases

      EUROPEAN CHILD & ADOLESCENT PSYCHIATRY
    32. Turri, MG; Datta, SR; DeFries, J; Henderson, ND; Flint, J
      QTL analysis identifies multiple behavioral dimensions in ethological tests of anxiety in laboratory mice

      CURRENT BIOLOGY
    33. Meagher, DJ
      Regular review - Delirium: optimising management

      BRITISH MEDICAL JOURNAL
    34. Ryan, CJ
      Optimising management of delirium - Placebo controlled trials of pharmacological treatments are needed

      BRITISH MEDICAL JOURNAL
    35. El Yacoubi, M; Ledent, C; Parmentier, M; Costentin, J; Vaugeois, JM
      Adenosine A(2A) receptor knockout mice are partially protected against drug-induced catalepsy

      NEUROREPORT
    36. See, RE; Berglind, WJ
      Decreased pallidal GABA following reverse microdialysis with, clozapine, but not haloperidol

      NEUROREPORT
    37. Shirayama, Y; Muneoka, KT; Takigawa, M; Minabe, Y
      Adenosine A(2A), 5-HT1A, and 5-HT7 receptor in neonatally pregnenolone-treated rats

      NEUROREPORT
    38. Miwa, H; Fuwa, T; Nishi, K; Kondo, T
      Subthalamo-pallido-striatal axis: a feedback system in the basal ganglia

      NEUROREPORT
    39. Qiao, H; Noda, Y; Kamei, H; Nagai, T; Furukawa, H; Miura, H; Kayukawa, Y; Ohta, T; Nabeshima, T
      Clozapine, but not haloperidol, reverses social behavior deficit in mice during withdrawal from chronic phencyclidine treatment

      NEUROREPORT
    40. Naidu, PS; Kulkarni, SK
      Excitatory mechanisms in neuroleptic-induced vacuous chewing movements (VCMs): possible involvement of calcium and nitric oxide

      BEHAVIOURAL PHARMACOLOGY
    41. Lanis, A; Schmidt, WJ
      NMDA receptor antagonists do not block the development of sensitization ofcatalepsy, but make its expression state-dependent

      BEHAVIOURAL PHARMACOLOGY
    42. Hauber, W; Neuscheler, P; Nagel, J; Muller, CE
      Catalepsy induced by a blockade of dopamine D-1 or D-2 receptors was reversed by a concomitant blockade of adenosine A(2A) receptors in the caudate-putamen of rats

      EUROPEAN JOURNAL OF NEUROSCIENCE
    43. Lipska, BK; Khaing, ZZ; Weickert, CS; Weinberger, DR
      BDNF mRNA expression in rat hippocampus and prefrontal cortex: effects of neonatal ventral hippocampal damage and antipsychotic drugs

      EUROPEAN JOURNAL OF NEUROSCIENCE
    44. Lucas, G; Di Matteo, V; De Deurwaerdere, P; Porras, G; Martin-Ruiz, R; Artigas, F; Esposito, E; Spampinato, U
      Neurochemical and electrophysiological evidence that 5-HT4 receptors exerta state-dependent facilitatory control in vivo on nigrostriatal, but not mesoaccumbal, dopaminergic function

      EUROPEAN JOURNAL OF NEUROSCIENCE
    45. Ovalle, S; Zamanillo, D; Andreu, F; Farre, AJ; Guitart, X
      Fibroblast growth factor-2 is selectively modulated in the rat brain by E-5842, a preferential sigma-1 receptor ligand and putative atypical antipsychotic

      EUROPEAN JOURNAL OF NEUROSCIENCE
    46. Roy, S; Tyrer, P
      Treatment of personality disorders

      CURRENT OPINION IN PSYCHIATRY
    47. Sabbe, B; Hulstijn, W
      Psychomotor disturbances in schizophrenia and depressive disorders

      CURRENT OPINION IN PSYCHIATRY
    48. Barnes, TRE; Joyce, EM
      Antipsychotic drug treatment: recent advances

      CURRENT OPINION IN PSYCHIATRY
    49. Markianos, M; Hatzimanolis, J; Lykouras, L
      Neuroendocrine responsivities of the pituitary dopamine system in male schizophrenic patients during treatment with clozapine, olanzapine, risperidone, sulpiride, or haloperidol

      EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
    50. Kahkonen, S; Ahveninen, J; Pekkonen, E; Kaakkola, S; Huttunen, J; Peltonen, T; Ilmoniemi, RJ; Jaaskelainen, IP
      No evidence for dependence of early cortical auditory processing on dopamine D-2-receptor modulation: a whole-head magnetoencephalographic study

      PSYCHIATRY RESEARCH-NEUROIMAGING
    51. Aleman, A; Kahn, RS
      Effects of the atypical antipsychotic risperidone on hostility and aggression in schizophrenia: a meta-analysis of controlled trials

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    52. Gefvert, O; Lundberg, T; Wieselgren, IM; Bergstrom, M; Langstrom, B; Wiesel, FA; Lindstrom, L
      D-2 and 5HT(2A) receptor occupancy of different doses of quetiapine in schizophrenia: a PET study

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    53. Araki, T; Mizutani, H; Matsubara, M; Imai, Y; Mizugaki, M; Itoyama, Y
      Nitric oxide synthase inhibitors cause motor deficits in mice

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    54. Naber, D; Karow, A
      Good tolerability equals good results: the patient's perspective

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    55. Kane, JM
      Extrapyramidal side effects are unacceptable

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    56. Kasper, S; Tauscher, J; Heiden, A
      Quetiapine: efficacy and tolerability in schizophrenia

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    57. Lynch, J; Morrison, J; Graves, N; Meddis, D; Drummond, MF; Hellewell, JSE
      The health economic implications of treatment with quetiapine: an audit oflong-term treatment for patients with chronic schizophrenia

      EUROPEAN PSYCHIATRY
    58. Silver, H; Shlomo, M
      Perception of facial emotions in chronic schizophrenia does not correlate with negative symptoms but correlates with cognitive and motor dysfunction

      SCHIZOPHRENIA RESEARCH
    59. Lubow, RE; Kaplan, O; De la Casa, G
      Performance on the visual search analog of latent inhibition is modulated by an interaction between schizotypy and gender

      SCHIZOPHRENIA RESEARCH
    60. Yasui-Furukori, N; Kondo, T; Suzuki, A; Mihara, K; Tokinaga, N; Inoue, Y; Otani, K; Kaneko, S
      Effect of the CYP2D6 genotype on prolactin concentration in schizophrenic patients treated with haloperidol

      SCHIZOPHRENIA RESEARCH
    61. Rascle, C; Mazas, O; Vaiva, G; Tournant, M; Raybois, O; Goudemand, M; Thomas, P
      Clinical features of latent inhibition in schizophrenia

      SCHIZOPHRENIA RESEARCH
    62. McGlashan, TH
      Psychosis treatment prior to psychosis onset: ethical issues

      SCHIZOPHRENIA RESEARCH
    63. Kowalski, J; Blada, P; Kucia, K; Madej, A; Herman, ZS
      Neuroleptics normalize increased release of interleukin-1 beta and tumor necrosis factor-alpha from monocytes in schizophrenia

      SCHIZOPHRENIA RESEARCH
    64. Knott, V; Labelle, A; Jones, B; Mahoney, C
      Quantitative EEG in schizophrenia and in response to acute and chronic clozapine treatment

      SCHIZOPHRENIA RESEARCH
    65. Naber, D; Moritz, S; Lambert, M; Rajonk, F; Holzbach, R; Mass, R; Andresen, B; Frank, P; Rudiger, H; Reinhard, M; Burghard, A
      Improvement of schizophrenic patients' subjective well-being under atypical antipsychotic drugs

      SCHIZOPHRENIA RESEARCH
    66. Rabinowitz, J; Davidson, M
      Risperidone versus haloperidol in long-term hospitalized chronic patients in a double blind randomized trial: a post hoc analysis

      SCHIZOPHRENIA RESEARCH
    67. Ganguli, R; Brar, JS; Ayrton, Z
      Weight gain over 4 months in schizophrenia patients: a comparison of olanzapine and risperidone

      SCHIZOPHRENIA RESEARCH
    68. Rasmussen, T; Fink-Jensen, A; Sauerberg, P; Swedberg, MDB; Thomsen, C; Sheardown, MJ; Jeppesen, L; Calligaro, DO; DeLapp, NW; Whitesitt, C; Ward, JS; Shannon, HE; Bymaster, FP
      The muscarinic receptor agonist BuTAC, a novel potential antipsychotic, does not impair learning and memory in mouse passive avoidance

      SCHIZOPHRENIA RESEARCH
    69. Cuesta, MJ; Peralta, V; Zarzuela, A
      Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: a longitudinal study

      SCHIZOPHRENIA RESEARCH
    70. Siris, SG; Addington, D; Azorin, JM; Falloon, IRH; Gerlach, J; Hirsch, SR
      Depression in schizophrenia: Recognition and management in the USA

      SCHIZOPHRENIA RESEARCH
    71. Masellis, M; Basile, VS; Meltzer, HY; Lieberman, JA; Sevy, S; Goldman, DA; Hamblin, MW; Macciardi, FM; Kennedy, JL
      Lack of association between the T -> C 267 serotonin 5-MT6 receptor gene (HTR6) polymorphism and prediction of response to clozapine in schizophrenia

      SCHIZOPHRENIA RESEARCH
    72. Kataoka, Y; Ishikawa, M; Miura, M; Takeshita, M; Fujita, R; Furusawa, S; Takayanagi, M; Takayanagi, Y; Sasaki, K
      Reversal of vinblastine resistance in human leukemic cells by haloperidol and dihydrohaloperidol

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    73. Sacristan, A; Gomez, JC; Badia, X; Kind, P
      Global index of safety (GIS): A new instrument to assess drug safety

      JOURNAL OF CLINICAL EPIDEMIOLOGY
    74. Taylor, MA
      Confessions of a drug user

      NEUROPSYCHIATRY NEUROPSYCHOLOGY AND BEHAVIORAL NEUROLOGY
    75. Kahkonen, S; Ahveninen, J; Jaaskelainen, IP; Kaakkola, S; Naatanen, R; Huttunen, J; Pekkonen, E
      Effects of haloperidol on selective attention - A combined whole-head MEG and high-resolution EEG study

      NEUROPSYCHOPHARMACOLOGY
    76. Cohen, BM; Yurgelun-Todd, D
      Alterations of thalamic activity in schizophrenia and in response to antipsychotic drugs - Studies in the legacy of Seymour S. Kety

      NEUROPSYCHOPHARMACOLOGY
    77. Moy, SS; Knapp, DJ; Breese, GR
      Effect of olanzapine on functional responses from sensitized D-1-dopamine receptors in rats with neonatal dopamine loss

      NEUROPSYCHOPHARMACOLOGY
    78. Feifel, D; Priebe, K; Shilling, PD
      Startle and sensorimotor gating in rats lacking CCK-A receptors

      NEUROPSYCHOPHARMACOLOGY
    79. Liechti, ME; Geyer, MA; Hell, D; Vollenweider, FX
      Effects of MDMA (ecstasy) on prepulse inhibition and habituation of startle in humans after pretreatment with citalopram, haloperidol, or ketanserin

      NEUROPSYCHOPHARMACOLOGY
    80. Stine, CD; Lu, WX; Wolf, ME
      Expression of AMPA receptor flip and flop mRNAs in the nucleus accumbens and prefrontal cortex after neonatal ventral hippocampal lesions

      NEUROPSYCHOPHARMACOLOGY
    81. Betancur, C; Lepee-Lorgeoux, I; Cazillis, M; Accili, D; Fuchs, S; Rostene, W
      Neurotensin gene expression and behavioral responses following administration of psychostimulants and antipsychotic drugs in dopamine D-3 receptor deficient mice

      NEUROPSYCHOPHARMACOLOGY
    82. Sevin, JA; Bowers-Stephens, C; Hamilton, ML; Ford, A
      Integrating behavioral and pharmacological interventions in treating clients with psychiatric disorders and mental retardation

      RESEARCH IN DEVELOPMENTAL DISABILITIES
    83. Silver, AA; Shytle, RD; Sheehan, KH; Sheehan, DV; Ramos, A; Sanberg, PR
      Multicenter, double-blind, placebo-controlled study of mecamylamine monotherapy for Tourette's disorder

      JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
    84. Kafantaris, V; Coletti, DJ; Dicker, R; Padula, G; Kane, JM
      Adjunctive antipsychotic treatment of adolescents with bipolar psychosis

      JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
    85. Masi, G; Cosenza, A; Mucci, M; Brovedani, P
      Open trial of risperidone in 24 young children with pervasive developmental disorders

      JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
    86. Wardas, J; Konieczny, J; Lorenc-Koci, E
      SCH 58261, an A(2A) adenosine receptor antagonist, counteracts parkinsonian-like muscle rigidity in rats

      SYNAPSE
    87. Danielsen, EH; Smith, D; Hermansen, F; Gjedde, A; Cumming, P
      Acute neuroleptic stimulates DOPA decarboxylase in porcine brain in vivo

      SYNAPSE
    88. Minabe, Y; Hashimoto, K; Watanabe, K; Ashby, CR
      Acute and repeated administration of the selective 5-HT2A receptor antagonist M100907 significantly alters the activity of midbrain dopamine neurons:An in vivo electrophysiological study

      SYNAPSE
    89. Bubser, M; Backstrom, JR; Sanders-Bush, E; Roth, BL; Deutch, AY
      Distribution of serotonin 5-HT2A receptors in afferents of the rat striatum

      SYNAPSE
    90. Rodriguez, JJ; Garcia, DR; Nakabeppu, Y; Pickel, VM
      FosB in rat striatum: Normal regional distribution and enhanced expressionafter 6-month haloperidol administration

      SYNAPSE
    91. Sakai, K; Gao, XM; Hashimoto, T; Tamminga, CA
      Traditional and new antipsychotic drugs differentially alter neurotransmission markers in basal ganglia-thalamocortical neural pathways

      SYNAPSE
    92. Roberts, RC
      Effect of chronic olanzapine treatment on striatal synaptic organization

      SYNAPSE
    93. Grimm, JW; Chapman, MA; Zahm, DS; See, RE
      Decreased choline acetyltransferase immunoreactivity in discrete striatal subregions following chronic haloperidol in rats

      SYNAPSE
    94. Tractenberg, RE; Gamst, A; Weiner, MF; Koss, E; Thomas, RG; Teri, L; Thal, L
      Frequency of behavioral symptoms characterizes agitation in Alzheimer's disease

      INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
    95. Morgenstern, H; Glazer, WM; Woods, SW
      Risperidone and tardive dyskinesia

      INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
    96. Cavallaro, R; Mistretta, P; Cocchi, F; Manzato, M; Smeraldi, E
      Differential efficacy of risperidone versus haloperidol in psychopathological subtypes of subchronic schizophrenia

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    97. Tsolaki, M
      Evaluation of tiapride in agitated elderly outpatients: an open study

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    98. Nemets, B; Fux, M; Levine, J; Belmaker, RH
      Combination of antidepressant drugs: The case of inositol

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    99. Morita, T; Tsunoda, J; Inoue, S; Chihara, S
      Effects of high dose opioids and sedatives on survival in terminally ill cancer patients

      JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
    100. Muriel, MP; Agid, Y; Hirsch, E
      Plasticity of afferent fibers to striatal neurons bearing D1 dopamine receptors in Parkinson's disease

      MOVEMENT DISORDERS


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 12/12/19 alle ore 10:05:27